• Melinda A. Lee
  • John R. Walsh


Anemia, monoclonal gammopathies, chronic lymphocytic leukemia (CLL), and myeloproliferative disorders are more common in elderly people. Despite an increasing prevalence, their detection may be delayed because many signs and symptoms may be attributed by both patients and providers to the aging process itself.


Multiple Myeloma Chronic Lymphocytic Leukemia Iron Deficiency Polycythemia Vera Mean Corpuscular Volume 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Timiras ML, Brownstein H. Prevalence of anemia and correlation of hemoglobin with age in a geriatric screening clinic population. JAm Geriatr Soc 1987; 35: 639–643.Google Scholar
  2. 2.
    Howe RB. Anemia in the elderly. Postgrad Med 1983; 73: 153–160.PubMedGoogle Scholar
  3. 3.
    Zauber NP, Zauber AG. Hematologic data of healthy very old people. JAMA 1987; 257: 2181–2184.PubMedCrossRefGoogle Scholar
  4. 4.
    Htoo MSH, Kofkoff RL, Freedman ML. Erythrocyte parameters in the elderly: an argument against new geriatric normal values. JAm Geriatr Soc 1979; 27: 547–551.Google Scholar
  5. 5.
    Lipschitz DA, Mitchell CO, Thompson C. The anemia of senescence. Am J Hematol 1981; 11: 47–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Lipschitz DA, Udupa KB, Milton KY, et al. Effect of age on hematopoiesis in man. Blood 1984; 63: 502–509.PubMedGoogle Scholar
  7. 7.
    Finch CA, Miller LR, Inamdar AR, et al. Iron deficiency in the rat: physiological and biochemical studies of muscle dysfunction. J Clin Invest 1976; 58: 447–453.PubMedCrossRefGoogle Scholar
  8. 8.
    Ohira Y, Edgerton VR, Gardiner GW, et al. Work capacity, heart rate and blood lactate responses to iron therapy. Br J Haematol 1979; 41: 365–372.PubMedCrossRefGoogle Scholar
  9. 9.
    Pinie R. The influence of age upon serum iron in normal subjects. J Clin Pathol 1952; 5: 10–15.CrossRefGoogle Scholar
  10. 10.
    Garry PJ, Goodwin JS, Hunt WC. Iron status and anemia in the elderly: new findings and a review of previous studies. JAm Geriatr Soc 1983; 31: 389–399.Google Scholar
  11. 11.
    Casale G, Bonora C, Migliavacca A, et al. Serum ferritin and ageing. Age Ageing 1981; 10: 119–122.PubMedCrossRefGoogle Scholar
  12. 12.
    Sharma JC, Roy SN. Value of serum ferritin as an index of iron deficiency in elderly anemic patients. Age Ageing 1984; 13: 248–250.PubMedCrossRefGoogle Scholar
  13. 13.
    Patterson C, Turpie ID, Benger AM. Assessment of iron stores in anemic geriatric patients. J Am Geriatr Soc 1985; 33: 764–767.PubMedGoogle Scholar
  14. 14.
    Lynch SR, Finch CA, Monsen ER, et al. Iron status of elderly Americans. Am J Clin Nutr 1982; 36: 1032–1045.PubMedGoogle Scholar
  15. 15.
    Marx JJM. Normal iron absorption and decreased red cell iron uptake in the aged. Blood 1979; 53: 204–211.PubMedGoogle Scholar
  16. 16.
    Cook JD. Clinical evaluations of iron deficiency. Semin Hematol 1982; 19: 6–18.PubMedGoogle Scholar
  17. 17.
    Lipschitz DA. Protein calorie malnutrition in the hospitalized elderly. Prim Care 1982; 9: 531–543.PubMedGoogle Scholar
  18. 18.
    Garry PJ, Goodwin JS, Hunt WC. Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc 1984; 32: 719–726.PubMedGoogle Scholar
  19. 19.
    Thompson WG, Babitz L, Cassino C, et al. Evaluation of current criteria used to measure vitamin B12 levels. Am J Med 1987; 82: 291–294.PubMedCrossRefGoogle Scholar
  20. 20.
    Grinbrat J, Marcus DL, Hernandez F, et al. Folate and vitamin B12 levels in an urban elderly population with chronic diseases. JAm Geriatr Soc 1986; 34: 627–632.Google Scholar
  21. 21.
    Carmel R, Simow R, Siegel ME, et al. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch Intern Med 1988; 148: 1715–1719.PubMedCrossRefGoogle Scholar
  22. 22.
    Lindenbaum J, Healton EB, Savage DG, et al. Neuro-psychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720–1728.PubMedCrossRefGoogle Scholar
  23. 23.
    Karnaze DS, Carmel R. Low serum cobalamin levels in primary degenerative dementia. Arch Intern Med 1987; 147: 429–431.PubMedCrossRefGoogle Scholar
  24. 24.
    Cole MG, Prchal JF. Low serum vitamin B12 in Alzheimer type dementia. Age Ageing 1984; 13: 101–105.PubMedCrossRefGoogle Scholar
  25. 25.
    Webster SGP, Leeming JT. Erythrocyte folate levels in young and old. JAm Geriatr Soc 1979; 27: 451–454.Google Scholar
  26. 26.
    Baker H, Frank O, Thind IS, et al. Vitamin profiles in elderly persons living at home or in nursing homes, versus profils in healthy young ones. J Am Geriatr Soc 1979; 27: 444–450.PubMedGoogle Scholar
  27. 27.
    Rosenberg IH, Bowman BB, Cooper BA, et al. Folate nutrition in the elderly. Am J Clin Nutr 1982; 36; 1060–1066.PubMedGoogle Scholar
  28. 28.
    Marcus DL, Freedman ML. Folic acid deficiency in the elderly. JAm Geriatr Soc 1985; 33: 552–558.Google Scholar
  29. 29.
    Gardner FH. Refractory anemia in the elderly. Adv Intern Med 1987; 32: 155–176.PubMedGoogle Scholar
  30. 30.
    Hartsock RI, Smith EB, Petty CS. Variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. Am J Clin Pathol 1965; 43: 326–331.PubMedGoogle Scholar
  31. 31.
    Lee MA, Segal GM, Bagby GC. The hematopoietic microenvironment in the elderly: defects in IL-1-induced CSF expression in vitro. Exp Hematol, 1989; 17: 952–956.PubMedGoogle Scholar
  32. 32.
    Boggs DR, Patrene KD. Hematopoiesis and aging: anemia and a blunted erythropoietic response to hemorrhage in aged mice. Am J Hematol 1985; 19: 327–338.PubMedCrossRefGoogle Scholar
  33. 33.
    Upuda KB, Lipschitz DA. Erythropoiesis in the aged mouse: response to stimulation in vivo. J Lab Clin Med 1984;103:574–580. Google Scholar
  34. 34.
    Upuda KB, Lipschitz DA. Erythropoiesis in the aged mouse: response to stimulation in vitro. J Lab Clin Med 1984; 103: 581–588.Google Scholar
  35. 35.
    Antin JH, Rosenthal DS. Acute leukemias, myelodysplasia and lymphomas. Clin Geriatr Med 1985; 1: 795–826.PubMedGoogle Scholar
  36. 36.
    Sebban C, Archimband E, Coiffier B, et al. Treatment of acute myeloid leukemia in elderly patients: a retrospective study. Cancer 1988; 61: 227–231.PubMedCrossRefGoogle Scholar
  37. 37.
    Walters RS, Kantarjian HM, Keating MJ, et al. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer 1987; 60: 149–155.PubMedCrossRefGoogle Scholar
  38. 38.
    Reiffers J, Raynal F, Boustet A. Acute myeloblastic leukemia in elderly patients: treatment and prognostic factors. Cancer 1980; 45: 2816–2820.PubMedCrossRefGoogle Scholar
  39. 39.
    Foon KA, Zighelboim K, Yale C, et al. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. Blood 1981; 58: 467–470.PubMedGoogle Scholar
  40. 40.
    Gale RP, Foon KA. Chronic lymphocytic leukemia: recent advances in biology and treatment. Ann Intern Med 1985; 103: 101–120.PubMedGoogle Scholar
  41. 41.
    Foon DA, Gale RP. Staging and therapy of chronic lymphocytic leukemia. Semin Hematol 1987; 24: 264–274.PubMedGoogle Scholar
  42. 42.
    Rai KR, Sarvitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234.PubMedGoogle Scholar
  43. 43.
    Report from the International Workshop on CLL. Chronic lymphocytic leukemia, proposals for a revised prognostic staging system. Br J Haematol 1981; 48: 365–367.CrossRefGoogle Scholar
  44. 44.
    Stahl R, Silber R. Chronic lymphocytic leukemia. Clin Geriatr Med 1985; 1: 857–867.PubMedGoogle Scholar
  45. 45.
    Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia: a randomized controlled clinical trial. N Engl J Med 1988; 319: 902–907.CrossRefGoogle Scholar
  46. 46.
    Cooper IA, Ding JC, Adams PB, et al. Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukemia (CLL) and lymphocytic lymphoma. Am J Hematol 1979; 6: 387–398.PubMedCrossRefGoogle Scholar
  47. 47.
    Maloney WC. Chronic myelogenous leukemia. Cancer 1978; 41: 865–873.CrossRefGoogle Scholar
  48. 48.
    Talpaz M, Kantarjian HM, Kurzrock R. Therapy of chronic myelogenous leukemia: chemotherapy and inter-ferons. Semin Hematol 1988; 25: 62–73.PubMedGoogle Scholar
  49. 49.
    Crawford S, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the “well” elderly. Am J Med 1987; 82: 39–45.PubMedCrossRefGoogle Scholar
  50. 50.
    Kyle RA. Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am J Med 1978; 64: 814–826.PubMedCrossRefGoogle Scholar
  51. 51.
    Cohen HJ. Monoclonal gammopathies and aging. Hosp Pract 1988; 30: 75–100.Google Scholar
  52. 52.
    Kyle RA, Bayrd ED. The Monoclonal Gammopathies: Multiple Myeloma and related Plasma-Cell disorders. Springfield, Ill: Charles C Thomas Publisher; 1976: 69.Google Scholar
  53. 53.
    Bergsagel DE, Rider WB. Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, Pa: JB Lippincott; 1985: 1753–1795.Google Scholar
  54. 54.
    Cohen HJ. Multiple myeloma in the elderly. Clin Geriatr Med 1985; 1: 827–855.PubMedGoogle Scholar
  55. 55.
    Savage DG, Lindenbaum J, Garrett TJ. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 1982; 96: 47–50.PubMedGoogle Scholar
  56. 56.
    Cohen HJ. Age and the treatment of multiple myeloma: southeastern cancer study group experience. Am J Med 1985; 79: 316–324.PubMedCrossRefGoogle Scholar
  57. 57.
    Dude BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842–854.CrossRefGoogle Scholar
  58. 58.
    Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1–12.PubMedGoogle Scholar
  59. 59.
    Gilbert H. Myeloproliferative disorders. Clin Geriatr Med 1985; 1: 773–793.PubMedGoogle Scholar
  60. 60.
    Silverstein MN, Remine WH. Splenectomy in myeloid metaplasia. Blood 1979; 53: 515–518.PubMedGoogle Scholar
  61. 61.
    Thomas DJ, Marshall J, Ross-Russel RW, et al. Cerebral blood-flow in polycythemia. Lancet 1977; 2: 161–163.PubMedCrossRefGoogle Scholar
  62. 62.
    Wade JPH, Pearson TC, Ross-Russell RW, et al. Cerebral blood flow and blood viscosity in patients with polycythemia secondary to hypoxic lung disease. Br Med J Clin Res 1981; 283: 689–692.CrossRefGoogle Scholar
  63. 63.
    York EL, Jones RL, Menon D, et al. Effects of secondary polycythemia on cerebral blood flow in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 121: 813–818.Google Scholar
  64. 64.
    Humphrey PRD, Marshall J, Ross-Russel RW, et al. Cerebral blood-flow and viscosity in relative polycythemia. Lancet 1979; 2: 873–876.PubMedCrossRefGoogle Scholar
  65. 65.
    Hocking WG. Primary and secondary erythrocytosis. In: Mazza J, ed. Manual of Clinical Hematology. Boston, Mass: Little Brown & Co Inc; 1988: 49–64.Google Scholar
  66. 66.
    Pearson TC, Wetherley-Mein G. Vascular occlusive episodes and venous hematocrit in primary proliferative polycythemia. Lancet 1978; 2: 1219–1222.PubMedCrossRefGoogle Scholar
  67. 67.
    Harrison MJG, Kendall BE, Pollack S, et al. Effect of hematocrit on carotid stenosis and cerebral infarction. Lancet 1981; 2: 114–115.PubMedCrossRefGoogle Scholar
  68. 68.
    Berk PD, Goldberg JD, Donovan PB, et al. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols. Semin Hematol 1986; 23: 132–143.PubMedGoogle Scholar
  69. 69.
    Cotes PM, Dore CJ, Yin JA, et al. Determination of serum erythropoietin in the investigation of erythrocytosis. N Engl J Med 1986; 315: 283–287.PubMedCrossRefGoogle Scholar
  70. 70.
    Landaw SA. Acute leukemia in polycythemia vera. Semin Hematol 1986; 23: 156–165.PubMedGoogle Scholar
  71. 71.
    Conley CL. Polycythemia vera diagnosis and treatment. Hosp Pract 1987; 22: 107–136.Google Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Melinda A. Lee
  • John R. Walsh

There are no affiliations available

Personalised recommendations